Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             46 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Assessing reduced-dose pneumococcal vaccine schedules in South Africa Dunne, Eileen M

20 12 p. 1355-1357
artikel
2 Bats and viruses Misra, Vikram

20 12 p. 1380
artikel
3 Catherine Wilfert Kazi, Farooq

20 12 p. 1378
artikel
4 Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study Grassly, Nicholas C

20 12 p. 1381-1389
artikel
5 Correction to Lancet Infect Dis 2020; 20: 1390–400
20 12 p. e298
artikel
6 Correction to Lancet Infect Dis 2020; 20: 1240–41
20 12 p. e298
artikel
7 Correction to Lancet Infect Dis 2020; 20: e251–60
20 12 p. e298
artikel
8 Correction to Lancet Infect Dis 2020; 20: e108–15
20 12 p. e298
artikel
9 Correction to Lancet Infect Dis 2020; published online Oct 5. https://doi.org/10.1016/S1473-3099(20)30480-1
20 12 p. e298
artikel
10 COVID-19 in Cameroon: a crucial equation to resolve Mbopi-Keou, Francois-Xavier

20 12 p. 1367-1368
artikel
11 COVID-19 on the African continent Wells, Chad R

20 12 p. 1368-1370
artikel
12 Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study Kuehl, Richard

20 12 p. 1409-1417
artikel
13 Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistance Wernli, Didier

20 12 p. e307-e311
artikel
14 Evolving viral and serological stages of Zika virus RNA-positive blood donors and estimation of incidence of infection during the 2016 Puerto Rican Zika epidemic: an observational cohort study Williamson, Phillip C

20 12 p. 1437-1445
artikel
15 Genetically modified mosquitoes Burki, Talha

20 12 p. 1375-1376
artikel
16 Has meningococcal serogroup A disease been eradicated? Obaro, Stephen

20 12 p. 1354-1355
artikel
17 Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT Lang, Min

20 12 p. 1365-1366
artikel
18 IDWeek 2020 Kazi, Farooq

20 12 p. 1374
artikel
19 Immunogenicity of a single-dose compared with a two-dose primary series followed by a booster dose of ten-valent or 13-valent pneumococcal conjugate vaccine in South African children: an open-label, randomised, non-inferiority trial Madhi, Shabir A

20 12 p. 1426-1436
artikel
20 Infectious disease surveillance update Zwizwai, Ruth

20 12 p. 1376
artikel
21 Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis Zhou, Guozhong

20 12 p. 1457-1469
artikel
22 Interferon-γ release assays or tuberculin skin test for latent tuberculosis infection? Mayanja-Kizza, Harriet

20 12 p. 1359-1360
artikel
23 Knowing the enemy: genetics to track antimalarial resistance Ménard, Didier

20 12 p. 1361-1362
artikel
24 Learning about Zika virus epidemiology and diagnostics from blood donor studies Petersen, Lyle R

20 12 p. 1357-1359
artikel
25 Long-term Zika virus infection of non-sperm cells in semen Mahé, Dominique

20 12 p. 1371
artikel
26 Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys Mbaeyi, Sarah

20 12 p. 1418-1425
artikel
27 Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study Imwong, Mallika

20 12 p. 1470-1480
artikel
28 No SARS-CoV-2 detected in amniotic fluid in mid-pregnancy Yu, Nan

20 12 p. 1364
artikel
29 Performance characteristics of five immunoassays for SARS-CoV-2: a head-to-head benchmark comparison
20 12 p. 1390-1400
artikel
30 Polymyxins resistance among Gram-negative pathogens in India Periasamy, Hariharan

20 12 p. 1362-1363
artikel
31 Pott's puffy tumour: a rare and life-threatening disease Ikoma, Nahoko

20 12 p. 1482
artikel
32 Predictive performance of interferon-γ release assays and tuberculin skin tests Hamada, Yohhei

20 12 p. 1371-1372
artikel
33 Predictive performance of interferon-γ release assays and tuberculin skin tests – Authors' reply Yang, Jiaru

20 12 p. 1372-1373
artikel
34 Progressive respiratory failure in COVID-19: a hypothesis Endeman, Henrik

20 12 p. 1365
artikel
35 Quantification and interpretation of attributable mortality in core clinical infectious disease journals von Cube, Maja

20 12 p. e299-e306
artikel
36 Research brief Devi, Sharmila

20 12 p. 1377
artikel
37 Risk of COVID-19 in health-care workers in Denmark: an observational cohort study Iversen, Kasper

20 12 p. 1401-1408
artikel
38 Rosanna Peeling—prioritising diagnostics worldwide Kirby, Tony

20 12 p. 1379
artikel
39 SARS-CoV-2 epidemic in African countries—are we losing perspective? Kalk, Andreas

20 12 p. 1370
artikel
40 Severe non-rheumatic streptococcal myocarditis requiring extracorporeal membrane oxygenation support Fox-Lewis, Andrew

20 12 p. 1481
artikel
41 Staphylococcus aureus bacteraemia: does duration matter? Tong, Steven Y C

20 12 p. 1353-1354
artikel
42 Testing COVID-19 therapies to prevent progression of mild disease Lipsitch, Marc

20 12 p. 1367
artikel
43 The complexities of SARS-CoV-2 serology Houlihan, Catherine F

20 12 p. 1350-1351
artikel
44 Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings Kucharski, Adam J

20 12 p. 1351-1352
artikel
45 Welcoming science back at the White House The Lancet Infectious Diseases,

20 12 p. 1349
artikel
46 Zika virus RNA and IgM persistence in blood compartments and body fluids: a prospective observational study Stone, Mars

20 12 p. 1446-1456
artikel
                             46 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland